Form 4 for PGEN PRECIGEN, INC.
Accepted 2023-08-18 00:00:00 ET · period of report 2023-08-16 · accession 0000950103-23-012318 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-18 | 2023-08-16 | PGEN | Sabzevari Helen | Pres, CEO, Dir | M - OptEx | — | +141.6K | 1.55M | +10% | — |
| D | 2023-08-18 | 2023-08-18 | PGEN | Sabzevari Helen | Pres, CEO, Dir | S - Sale+OE | $1.66 | -55.9K | 1.50M | -4% | -$92.7K |
| D | 2023-08-18 | 2023-08-16 | PGEN | Sabzevari Helen | Pres, CEO, Dir | M - OptEx | $0.00 | -141.6K | 141.6K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-16 | M | A | 141,587 | — | 1,551,241 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. |
| 2 | Common | Common Stock | 2023-08-18 | S | D | 55,855 | $1.66 | 1,495,386 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2023-08-16 | M | D | 141,587 | $0.00 | 141,587 | D | — · — to — | 141,587 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. (F3) Represents 1/6 of the RSUs granted on March 24, 2023 that vested on August 16, 2023. The remaining RSUs vest on August 23, 2023. |